Sumitoma Pharma US
Melissa Oberg is an accomplished finance professional currently serving as Executive Director of Financial Planning & Analysis at Sumitomo Pharma America, Inc. since July 2023. Prior to this role, Melissa held various leadership positions at Urovant Sciences, Inc., including Executive Director and Senior Director of Revenue and Forecasting, from September 2020 to July 2023. With extensive experience at Astellas Pharma US from December 2007 to September 2020, Melissa advanced through several roles, ultimately serving as Director of Commercial Finance, where responsibilities included financial advisory and expense management for the US Commercial organization. Melissa began her career at the Chicago Tribune Company and OSRAM SYLVANIA PRODUCTS INC. Educational credentials include an MBA in Leadership and a Bachelor of Science in Business Administration with a focus on Financial Services, both from Bryant University.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.